Peng Block or Suprascapular Nerve Block for Postoperative Analgesia in Shoulder Artroscopy ?

NCT05666076 | Completed DMC

• 1 other identifier: 2022-360
• Study Type: interventional
• Target: 74
• Locations: 1 country
• Sites: 1

Brief Summary

Arthroscopic shoulder surgery, which has been frequently applied in recent years, provides long-term positive clinical results and increases the quality of life after surgery, while it can cause severe pain in the early postoperative period. Postoperative pain management is very important in shoulder arthroplasty. Adequate pain control; mental state, nutrition, cost of care, rehabilitation, and patient satisfaction, are of great importance for the patients' recovery and contribute to a successful surgical outcome. In this study, the investigators aimed to compare the effects of suprascapular nerve block and shoulder pericapsular nerve block, which will be performed preoperatively with ultrasound, on the level of postoperative pain in patients who will undergo shoulder arthroscopy surgery under general anesthesia.

Conditions

Orthopedic Disorder; Shoulder Pain; Surgery; Analgesia

Keywords

peng block; suprascapular nerve block; postoperative analgesia

Outcome Measures

Primary Outcomes (1)

• The primary outcome measure of the study is the patients' postoperative pain scores (NRS)

  Numerical rating scale (NRS) at 1, 6, 12, 18, 24, 30, and 36th hours. A numerical rating scale (NRS) requires the patient to rate their pain on a defined scale. For example, 0-10 where 0 is no pain and 10 is the worst pain imaginable.

  36 hours postoperatively

Secondary Outcomes (1)

• Postoperative 36-hour total tramadol hydrochloride consumption

  36 hours postoperatively

Study Arms (2)

Group PENG

ACTIVE COMPARATOR

The investigators performed a pericapsular nerve block on that patient group for postoperative analgesia.

Procedure: Pericapsular nerve block; Drug: Bupivacaine Hydrochloride

Group SSNB

ACTIVE COMPARATOR

The investigators performed a suprascapular nerve block on that patient group for postoperative analgesia.

Procedure: Suprascapular nerve block; Drug: Bupivacaine Hydrochloride

Interventions

Pericapsular nerve block PROCEDURE

The investigators will perform a pericapsular nerve block on that patient group for postoperative analgesia in shoulder arthroscopy.

Group PENG

Suprascapular nerve block PROCEDURE

The investigators will perform a suprascapular nerve block on that patient group for postoperative analgesia in shoulder arthroscopy.

Group SSNB

Bupivacaine Hydrochloride DRUG

The investigators will perform a pericapsular nerve block on that patient group for postoperative analgesia with bupivacaine hydrochloride

Group PENG

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients who will have shoulder arthroscopy surgery under general anesthesia
• Ages of 18-75
• ASA I-III

You may not qualify if:

• Patients with deformity and pathology in the shoulder region
• Patients with known local anesthetic allergy
• Patients with BMI\>35
• Patients with alcohol and substance addiction
• Patients with opioid addiction
• Patients who cannot perceive and evaluate pain, such as psychiatric illness, mental retardation

Sponsors & Collaborators

• Bakirkoy Dr. Sadi Konuk Research and Training Hospital: lead

Study Sites (1)

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Istanbul, Bakirkoy, 34147, Turkey (Türkiye)

Location

Related Publications (2)

• Sun C, Zhang X, Ji X, Yu P, Cai X, Yang H. Suprascapular nerve block and axillary nerve block versus interscalene nerve block for arthroscopic shoulder surgery: A meta-analysis of randomized controlled trials. Medicine (Baltimore). 2021 Nov 5;100(44):e27661. doi: 10.1097/MD.0000000000027661.

  PMID: 34871240 BACKGROUND

• Kupeli I, Yazici Kara M. Anesthesia or analgesia? New block for shoulder surgery: pericapsular nerve group block. Braz J Anesthesiol. 2022 Sep-Oct;72(5):669-672. doi: 10.1016/j.bjane.2021.05.009. Epub 2021 Jun 9.

  PMID: 34118263 BACKGROUND

MeSH Terms

Conditions

Musculoskeletal Diseases; Shoulder Pain; Agnosia

Interventions

Bupivacaine

Condition Hierarchy (Ancestors)

Arthralgia; Joint Diseases; Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Perceptual Disorders; Neurobehavioral Manifestations; Nervous System Diseases

Intervention Hierarchy (Ancestors)

Anilides; Amides; Organic Chemicals; Aniline Compounds; Amines

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal investigator

Study Record Dates

• First Submitted: November 28, 2022
• First Posted: December 27, 2022
• Study Start: January 2, 2024
• Primary Completion: April 17, 2024
• Study Completion: April 29, 2024
• Last Updated: June 11, 2025

Record last verified: 2025-06

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, ICF
• Time Frame: Two year within the publication date.

Locations

TU (1)